Rahul Saluja, Senior Executive and Thought Leader in Life Sciences.

The interventional oncology market valued at US$ 2.53 Billion in 2023, is forecasted to grow at a robust CAGR of 9.0%, reaching US$ 2.75 Billion in 2024 and an impressive US$ 4.24 Billion by 2029. The ...

AI-powered technology enhances fetal heart screenings, improving early detection rates of congenital heart defects for better newborn care. AI enhances accuracy in fetal heart screening ...